CFO of Keryx Biopharmaceuticals Inc. (KERX, Financial) James F Iii Oliviero sells 4,559 shares of KERX on 07/03/2012 at an average price of $1.99 a share.
Keryx Biopharmaceuticals has a market cap of $128.2 million; its shares were traded at around $1.94 with and P/S ratio of 25.6.
For the complete insider trading history of KERX, click here.
Keryx Biopharmaceuticals has a market cap of $128.2 million; its shares were traded at around $1.94 with and P/S ratio of 25.6.
CEO Recent Trades:
- CEO Ron Bentsur bought 19,100 shares of KERX stock on 04/18/2012 at the average price of 1.3. Ron Bentsur owns at least 479,476 shares after this. The price of the stock has increased by 49.23% since.
CFO Recent Trades:
- CFO James F Oliviero Iii sold 5,458 shares of KERX stock on 04/05/2012 at the average price of 1.6. James F Oliviero Iii owns at least 176,560 shares after this. The price of the stock has increased by 21.25% since.
Directors and Officers Recent Trades:
- Director Michael P. Tarnok bought 17,500 shares of KERX stock on 04/05/2012 at the average price of 1.55. Michael P. Tarnok owns at least 278,600 shares after this. The price of the stock has increased by 25.16% since.
- Director Joseph M Feczko bought 20,000 shares of KERX stock on 04/05/2012 at the average price of 1.62. Joseph M Feczko owns at least 70,000 shares after this. The price of the stock has increased by 19.75% since.
For the complete insider trading history of KERX, click here.
